Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Ecology and Evolution
|
September 21, 2020
Visualizing connectivity of ecological and evolutionary concepts-An exploration of research on plant species rarity
Thomas P Wiegand, Braley Gentry, Zachary McCoy, et al.
Pharmacogenetics and Genomics
|
October 19, 2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease
Rafael Blesa, Roger Bullock, Yunsheng He, et al.
International Journal of Geriatric Psychiatry
|
March 24, 2007
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule
Bengt Winblad, Jeffrey Cummings, Niels Andreasen, et al.
Alzheimer Disease and Associated Disorders
|
June 3, 2009
Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension
George Grossberg, Carl Sadowsky, Hans Fröstl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 16, 2013
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
Fabrizio Stocchi, Olivier Rascol, Alain Destee, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Ecology and Evolution
|
September 21, 2020
Visualizing connectivity of ecological and evolutionary concepts-An exploration of research on plant species rarity
Thomas P Wiegand, Braley Gentry, Zachary McCoy, et al.
Pharmacogenetics and Genomics
|
October 19, 2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease
Rafael Blesa, Roger Bullock, Yunsheng He, et al.
International Journal of Geriatric Psychiatry
|
March 24, 2007
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule
Bengt Winblad, Jeffrey Cummings, Niels Andreasen, et al.
Alzheimer Disease and Associated Disorders
|
June 3, 2009
Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension
George Grossberg, Carl Sadowsky, Hans Fröstl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 16, 2013
AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
Fabrizio Stocchi, Olivier Rascol, Alain Destee, et al.
Page
of 2